ADVFN US – Market Content Editor
-
Lumentum and Coherent shares jump after Nvidia commits $2 billion investments in advanced optics
Shares of Lumentum (NASDAQ:LITE) and Coherent (NYSE:COHR) surged in premarket trading after artificial intelligence leader Nvidia (NASDAQ:NVDA) announced plans to invest $2 billion in each company to accelerate development of next-generation optical technologies. Under the agreements, Nvidia will also make purchase commitments for the companies’ products, which are designed to improve data transfer speed and…
-
nLIGHT to present high-energy laser weapon technologies at 2026 POST Conference
nLIGHT, Inc. (NASDAQ:LASR), a provider of high-power laser systems used in directed energy, optical sensing and advanced manufacturing applications, announced that it will exhibit a range of its high-energy laser weapon solutions at the Pacific Operational Science & Technology (POST) Conference, taking place March 9–12, 2026, in Honolulu, Hawaii. During the event, the company plans…
-
Rallybio to acquire Candid Therapeutics in $505M merger deal
Rallybio Corporation (NASDAQ:RLYB) announced plans to acquire Candid Therapeutics through a merger agreement, with the combined entity set to operate under the name Candid Therapeutics and trade using the ticker symbol CDRX. The transaction is accompanied by a concurrent private financing expected to generate more than $505 million in gross proceeds. Participants in the financing…
-
Rubico estimates net asset value at $94.2 million
Rubico Inc. (NASDAQ:RUBI), a global shipping transportation company focused on vessel ownership, announced that management has calculated an estimated net asset value (NAV) of $94.2 million as of December 31, 2025. The estimate incorporates updated charter-free vessel valuations provided by an independent international broker, along with the company’s outstanding debt and cash position. Based on…
-
Wall Street set for sharp drop as U.S. strikes on Iran rattle markets: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures pointed to a sharply lower open on Monday, suggesting equities could extend losses after two consecutive sessions of declines. Market sentiment weakened following joint U.S. and Israeli military strikes on Iran over the weekend that resulted in the death of Iranian Supreme Leader Ayatollah Ali Khamenei. Tensions escalated further after Israel…
-
Barclays advises waiting for deeper S&P 500 pullback before buying equities
Global equity markets are preparing for a volatile start after the United States and Israel launched Operation Judas Shield, a preemptive military strike on Iran that triggered rapid retaliation across the Middle East. Iran responded with missile attacks targeting U.S. military installations and allied locations across the region, with explosions reported in Dubai, Riyadh, Abu…
-
Kosmos Energy guides lower exploration spending, beats forecasts
Kosmos Energy (NYSE:KOS) released its 2026 outlook on Monday, forecasting exploration expenditures of between $10 million and $30 million — well below the Bloomberg consensus estimate of $48 million. The company expects annual production to average between 70,000 and 78,000 barrels of oil equivalent per day. Capital spending for 2026 is projected at approximately $350…
-
Compugen shares jump nearly 5% after strong Q4 earnings beat
Compugen Ltd. (NASDAQ:CGEN) shares climbed almost 5% in premarket trading on Monday after the company reported fourth-quarter results that far exceeded analyst expectations, supported by a strategic royalty monetization deal with AstraZeneca. The clinical-stage cancer immunotherapy developer posted adjusted earnings per share of $0.60 for the quarter, sharply outperforming the analyst consensus forecast of a…
-
Xeris Biopharma shares rise nearly 3% after Q4 earnings beat and strong 2026 outlook
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) shares gained nearly 3% in premarket trading on Monday after the company reported fourth-quarter results that topped analyst expectations and issued 2026 revenue guidance above consensus forecasts. The biopharmaceutical company posted adjusted earnings per share of $0.06 for the fourth quarter, exceeding analyst estimates of $0.02 by $0.04. Quarterly revenue…
-
Sealed Air tops Q4 forecasts on stronger revenue and earnings performance
Sealed Air Corporation (NYSE:SEE) reported fourth-quarter results on Monday that came in ahead of analyst expectations, with both revenue and earnings exceeding consensus forecasts. The company posted adjusted earnings per share of $0.77, surpassing the analyst estimate of $0.73. Shares were little changed following the announcement, edging up 0.05% in premarket trading. Quarterly revenue totaled…